Atabay Pharmaceutical
Atabay was founded in Istanbul by Mr. Ö. Kemalettin Atabay, Pharmacist, in 1939, prior to the outbreak of the Second World War. The company had emerged as a trading business, importing and marketing pharmaceutical products. In the 1940’s, this medium sized commercial operation developed into the production of sulfonamide tablets, which were in great demand at the time, thus paving the way to the pharmaceutical industry in Turkey.
tons of raw material production capacity
The sole manufacturer of
p-Aminophenol and Paracetamol in EMEA
+ API Development and Manufacturing
Pioneer in active pharmaceutical ingredient manufacturing — active substances for human, veterinary, and agrochemical applications
country raw material export reach
Exports to 67 Countries · 470 Licenses · 47 Distributors
+ employees
1,200+ employees across our overseas offices, Gebze facility, Acıbadem facility, and headquarters.
News & Announcements
Women Leaders Driving the Future
In our conversation with Ayşe Atabay and Zeynep Atabay Taşkent — next-generation leaders of the Atabay Family, one of the pharmaceutical sector’s most established dynasties — on the subject of women executives and leaders in the industry, Atabay Pharmaceuticals Board Chair Zeynep Atabay Taşkent answered our questions and shared key messages for women in leadership.
A Groundbreaking Achievement from Atabay: 100% Domestic ‘From Seed to Shelf’ Herbal Medicine Production!
A Groundbreaking Achievement from Atabay: 100% Domestic 'From Seed to Shelf' Herbal Medicine Production! The pharmaceutical sector is one of a country's strategic domains. Approximately 90% of the medicines consumed in our country are domestically produced, while the...
Thought Leaders — National Projection: Atabay
Thought Leaders — National Projection: Atabay In the latest issue of Thought Leaders Magazine, Atabay Board Chairperson Zeynep Atabay Taşkent, Vice Chairperson of the Board Ayşe Atabay, and Strategy & R&D Director Doğan Taşkent joined us as guests, providing...
Altın Havan Awards 2025 | We Achieved It Together
As Atabay, we are delighted that our R&D work toward the domestic industrial-scale production of Acetylcysteine API has been recognized with the R&D Award at the Altın Havan (Golden Mortar) Awards 2025.This achievement is the result of a comprehensive body of...
Atabay Returns from the Turkish Medical World Congress and TÜSEB Productive Health Business Forum with an Award
Atabay Returns from the Turkish Medical World Congress and TÜSEB Productive Health Business Forum with an Award At the 11th Turkish Medical World Congress and TÜSEB Productive Health Business Forum, held in Ankara from 24–26 November 2025 under the auspices of the...
The Right Address for a Holistic Solution Approach: The Medical Department
UZM. DR. MURAT YAYCIATABAY Medical Director The Right Address for a Holistic Solution Approach: The Medical Department Atabay Medical Director Specialist Dr. Murat Yaycı, who states "We chart our own roadmap — and that is precisely where the difference lies,"...
Research and Development
Biotechnology & Vaccine
Atabay İlaç has completed the establishment of a facility to produce biosimilar drugs with the Biotechnology Group and continues its activities.
Effective Substance Synthesis
Atabay, which has a long history in pharmaceutical chemical synthesis, produces the active ingredients of very important human medicines in its facilities.
Sterile Production
Our facility has a production capacity of one million monthly and twelve million vials annually and has both aseptic filling and vial production capabilities.
OUR CERTIFICATES
